Evolution of the Average Target: Centene Corporation

Evolution of the Target Price: Centene Corporation

Changes in Analyst Recommendations: Centene Corporation

91f9b14563.yYfmVhq2AD3h1CHdMWFIKfDAcU1n0ql1t7xPE-jSBHc.keWrI1mDZF6SgGqxfhIGQMSqMAwSi-Es7toFSa-LVkauzpwGfP5GCoiEdA~ab4165176e9f56b327fac6b2a10e71d7
08/06 JPMorgan Adjusts Price Target on Centene to $60 From $52, Maintains Neutral Rating MT
04/06 UnitedHealth, CVS, Cigna Seen Benefiting From Utilization Trends, AI Upside, Morgan Stanley Says MT
04/06 Morgan Stanley Raises Price Target on Centene to $57 From $50, Keeps Equalweight Rating MT
04/06 Morgan Stanley Adjusts Price Target on Centene to $57 From $50, Maintains Equalweight Rating MT
01/06 Truist Raises Price Target on Centene to $71 From $58, Keeps Buy Rating MT
27/05 Oppenheimer Adjusts Centene Price Target to $67 From $58, Maintains Outperform Rating MT
26/05 Barclays Adjusts Price Target on Centene to $75 From $63, Maintains Overweight Rating MT
22/05 UBS Adjusts Price Target on Centene to $61 From $55, Maintains Neutral Rating MT
21/05 BofA Securities Lifts Price Target on Centene to $72 From $60 MT
20/05 Deutsche Bank Upgrades Centene to Buy From Hold, Adjusts PT to $80 From $53 MT
20/05 Mizuho Adjusts Price Target on Centene to $58 From $50, Maintains Neutral Rating MT
05/05 Bernstein Adjusts Price Target on Centene to $68 From $48, Maintains Outperform Rating MT
05/05 JPMorgan Adjusts Price Target on Centene to $52 From $41, Maintains Neutral Rating MT
04/05 U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower RE
01/05 Wells Fargo Adjusts Centene Price Target to $56 From $44 MT
29/04 Morgan Stanley Adjusts Price Target on Centene to $50 From $45, Maintains Equalweight Rating MT
29/04 Mizuho Adjusts Price Target on Centene to $50 From $41, Maintains Neutral Rating MT
29/04 Truist Raises Price Target on Centene to $58 From $49, Keeps Buy Rating MT
29/04 Oppenheimer Adjusts Price Target on Centene to $58 From $45, Maintains Outperform Rating MT
29/04 Deutsche Bank Adjusts Centene Price Target to $53 From $39, Maintains Hold Rating MT
29/04 UBS Adjusts Price Target on Centene to $55 From $42, Maintains Neutral Rating MT
29/04 Barclays Adjusts Centene Price Target to $63 From $54, Maintains Overweight Rating MT
29/04 Jefferies Adjusts Centene Price Target to $48 From $39, Maintains Hold Rating MT
29/04 Goldman Sachs Adjusts Centene Price Target to $40 From $32, Maintains Sell Rating MT
29/04 Cantor Fitzgerald Upgrades Centene to Overweight From Neutral, Adjusts PT to $60 From $41 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-0.06%
-0.07%
+4.53%
+16.66%
-18.37%
-4.97%
+20.99%
-15.99%
+11.76%
Average +1.61%
Weighted average by Cap. +1.36%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
61.39USD
Average target price
61.35USD
Spread / Average Target
-0.06%
High Price Target
80.00USD
Spread / Highest target
+30.31%
Low Price Target
40.00USD
Spread / Lowest Target
-34.84%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JPMorgan Chase
Morgan Stanley
Truist Securities
Oppenheimer
Barclays
UBS
BofA Securities
Deutsche Bank Securities
Mizuho Securities
Bernstein
Wells Fargo Securities
Goldman Sachs
Jefferies & Co.
Cantor Fitzgerald
Baird
TD Cowen
Guggenheim
Stephens Inc.
Argus
Wolfe Research
Credit Suisse
Cowen
Loop Capital
BMO Capital
Citigroup
Seaport Global Securities
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
61.39USD
Average target price
61.35USD
Spread / Average Target
-0.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CNC Stock
  4. Consensus Centene Corporation
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!